WZ4003 sensitizes non-small cell lung cancer cells to gefitinib via inhibition of ARK5 and epithelial-to-mesenchymal transition

Gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, is used as a first-line treatment for advanced non-small cell lung cancer (NSCLC); however, its utility is hampered by the development of chemoresistance. This study aimed to investigate the synergistic role of WZ4003, a novel...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Am J Transl Res
Huvudupphovsmän: Chen, Jiabin, Zhang, Shufen, Zheng, Xiaoxiao, Mao, Jiayan, Xie, Shangzhi, Chen, Wei, Ran, Xiangui
Materialtyp: Artigo
Språk:Inglês
Publicerad: e-Century Publishing Corporation 2020
Ämnen:
Original Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7724321/
https://ncbi.nlm.nih.gov/pubmed/33312374
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk